Leon L’Huillier – Executive Chairman
Executive Chairman, Leon L’Huillier has a respected track record as a business man in his roles as a Chairman or Director of Medical Research, health and road trauma organisations. He is currently Deputy Chairman of Australian Prostate Cancer Research. He is former Chairman of the Vision CRC at the University of NSW, the world’s leading centre for cornea and contact lens applied research.
Other Board appointments include being a former Chairman of the Australian Health Ministers Advisory Council, Chairman, the Royal Children’s Hospital, Brisbane and Director of the National Health and Medical Research Council. He is former Director of St. Vincent’s Hospital, Melbourne and the O’Brien Institute that carries out internationally recognised scientific research in the fields of Tissue Engineering and Vascular Biology. He was Chief of Health Department Victoria where he introduced a large number of reforms.
As Executive Chairman of Victoria’s Transport Accident Commission he developed and introduced the innovative TAC road safety campaigns, which reduced Victoria’s road toll by almost 50% in three years. He won a Cannes Golden Lion and received international recognition for his pioneering work. In private equity he has worked with major Australian firms including Macquarie Bank, Grant Samuel, Archer Capital, Ironbridge and Gresham.
A former Director and Audit Chairman of Woolworths Limited, Director of Challenge Bank and MLC Limited, Chairman, Lend Lease Investment Board and the Australian Prime Property Fund Limited. He is a former Director of Price Waterhouse Australian Policy Board. He has been a CEO of fast moving consumer goods (FMCG) companies.
Qualifications: MBA, (Chicago), MPhil, (London), BCom (Hons) (Melbourne), FAICD
David Ashmore – Independent Non-Executive Director
David Ashmore is a Fellow of the Institute of Chartered Accountants, a Fellow of the Financial Services Institute of Australasia and a Graduate of the Institute of Company Directors. He has over 40 years of professional assurance services experience and is a former senior partner at Grant Thornton Australia and one of its predecessor firms and was a leader in the audit services division for many years. David is an Independent Director and Chairman of Saferoads Holdings Ltd and holds a number of other private company directorships and appointments as an independent member of Audit and Risk Management Committees.
Qualifications: FCA, GAICD, F.FIN
Ross Blair-Holt – Independent Non-Executive Director
Ross Blair-Holt brings to the iSonea Board a number of skills, including strategic and structured decision making at all levels of finance expertise, business processes, risk management, and governance. After working at General Credits Finance Company and Citibank until 1986, Ross has worked for the Bruce Mathieson Group of private companies from 1986. He is currently Director and CEO of all these companies. In addition, from 2004 to 2014, Ross was Chief Operating Officer of ALH Group, owner of 330 Hotels across Australia. ALH is owned 75% by Woolworths Ltd and 25% by Mathieson Group. Ross remains a Director of the ALH Group, as well as being a member of the ALH Audit and Risk
Qualifications: BCom (Melbourne), CPA.
Dr. Tim Oldham– Independent Non-Executive Director
Timothy Oldham has more than a decade of direct life sciences business development, alliance management, market entry, and sales & marketing experience in Europe, Asia and Australia. He is CEO of Cell Therapies Pty Ltd, a leading Asia Pacific provider of collection, manufacturing, delivery and distribution capabilities for stem cell therapies and regenerative medicine and was President of Asia Pacific for Hospira, Inc. (2007 to 2012), having held a variety of senior management roles with Mayne Pharma (2002 to 2007) prior to its acquisition by Hospira. These roles encompass the development and commercialisation of pharmaceuticals, devices, biologics and cellular therapies. Prior to this, Tim was an engagement manager with McKinsey & Co (1997 to 2001). He has been chairman of the European Generic Medicines Association Biosimilars and Biotechnology Committee, a Director of the Generic Medicines Industry Association and a member of the Pharmaceutical Industry Strategy Group. He is a also a Director of Acrux Ltd (ASX:ACR).
Qualifications: BSc (Hons), LLB (Hons), PhD, GAICD
John Ribot de Bresac – Independent Non-Executive Director
John has extensive experience and a strong record of achievement as a senior executive across consumer facing businesses in the sport, leisure and hospitality industries including in strategy development and implementation. Following a distinguished sports career where he received the Australian Sports Medal, he was instrumental in the establishment of the Brisbane Broncos and Melbourne Storm, in executive Director roles, and as chairman of the Brisbane Roar. Currently John serves as Director of Victorian Major Events Company, executive chairman of Queensland Clubs Management (QCM), and owns hospitality venues throughout Queensland.
Dr Catherine Downes: Dr Downes is a General Practitioner who has practiced in London and Australia. Dr Downes has been a Principal of several large medical centers in Queensland and currently practices in a Sydney CBD medical center. She has also served as a Government Medical Officer in Queensland and attended Magistrate, District and Supreme courts as an expert medical witness.